1. Home
  2. BEAM vs NWBI Comparison

BEAM vs NWBI Comparison

Compare BEAM & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
  • NWBI
  • Stock Information
  • Founded
  • BEAM 2017
  • NWBI 1896
  • Country
  • BEAM United States
  • NWBI United States
  • Employees
  • BEAM N/A
  • NWBI N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • NWBI Major Banks
  • Sector
  • BEAM Health Care
  • NWBI Finance
  • Exchange
  • BEAM Nasdaq
  • NWBI Nasdaq
  • Market Cap
  • BEAM 1.9B
  • NWBI 1.9B
  • IPO Year
  • BEAM 2020
  • NWBI N/A
  • Fundamental
  • Price
  • BEAM $29.01
  • NWBI $13.35
  • Analyst Decision
  • BEAM Buy
  • NWBI Hold
  • Analyst Count
  • BEAM 10
  • NWBI 3
  • Target Price
  • BEAM $47.67
  • NWBI $12.67
  • AVG Volume (30 Days)
  • BEAM 1.2M
  • NWBI 713.5K
  • Earning Date
  • BEAM 11-05-2024
  • NWBI 01-21-2025
  • Dividend Yield
  • BEAM N/A
  • NWBI 5.99%
  • EPS Growth
  • BEAM N/A
  • NWBI N/A
  • EPS
  • BEAM N/A
  • NWBI 0.76
  • Revenue
  • BEAM $349,643,000.00
  • NWBI $487,913,000.00
  • Revenue This Year
  • BEAM N/A
  • NWBI N/A
  • Revenue Next Year
  • BEAM $10.82
  • NWBI $5.89
  • P/E Ratio
  • BEAM N/A
  • NWBI $17.58
  • Revenue Growth
  • BEAM 328.73
  • NWBI N/A
  • 52 Week Low
  • BEAM $20.84
  • NWBI $10.45
  • 52 Week High
  • BEAM $49.50
  • NWBI $15.42
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 56.94
  • NWBI 33.54
  • Support Level
  • BEAM $24.96
  • NWBI $14.15
  • Resistance Level
  • BEAM $29.53
  • NWBI $14.64
  • Average True Range (ATR)
  • BEAM 2.05
  • NWBI 0.37
  • MACD
  • BEAM -0.04
  • NWBI -0.17
  • Stochastic Oscillator
  • BEAM 67.05
  • NWBI 16.76

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About NWBI Northwest Bancshares Inc.

Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution offering personal and banking business solutions, investment management, trust services and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and business banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Business banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.

Share on Social Networks: